Skip to content
2000
Volume 18, Issue 29
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Autoimmunity is an overreaction of immune competent cells to self structures resulting in an unwanted clinical outcome. Traditional therapeutic strategies, still relevant in many cases, involve broad acting immunosuppressants such as cyclophosphamide with the predictable attendant toxicity. More recent concepts include blockade of specifically defined targets such as TNF-α, with resulting immunomodulation and less toxicity. Both of these strategies require ongoing drug treatment of established disease. A long standing goal, not yet achieved, is the predictable induction of tolerance, obviating the need for chronic treatment. Experimental strategies to achieve this include pre-emptive (preclinical) treatment before chronification is established, total immune ablation and immune “resetting” and autoantigen immunisation.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161212802502170
2012-10-01
2025-04-19
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161212802502170
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test